COVID-19 related hospitalizations have doubled since April and deaths remain at about 350 a day, said Dr. Rochelle Walensky, director of the CDC.
to receive updates directly to your inbox and join our Facebook group.
“Over 50% of all Americans have had COVID now, so people think, ‘Well, I already had COVID and I did fine so why would I need another vaccine?’” he said. “There’s a lot of malaise and complacency.” the COVID-19 pandemic may have reversed years of progress combatting antimicrobial resistant in the U.S.
Neither the antidepressant fluvoxamine, often used to treat obsessive-compulsive disorder, nor the gout drug colchicine, was shown to provide benefit to COVID-19 patients. The study, published Thursday in"Nature Genetics," concluded people of European and African ancestries with variants of the OAS1 gene had longer COVID-19 infections than others without the variants. The findings suggest people who carry this genetic risk might benefit from treatment with interferons, proteins that can help the body’s immune system fight infection.